HRT Financial’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.32M Sell
21,800
-13,700
-39% -$3.19M 0.01% 1094
2025
Q4
$9.52M Buy
35,500
+100
+0.3% +$25.4K 0.03% 478
2025
Q3
$8.73M Buy
35,400
+11,600
+49% +$3.02M 0.03% 437
2025
Q2
$7.11M Buy
23,800
+3,600
+18% +$1.1M 0.03% 407
2025
Q1
$6.3M Buy
+20,200
New +$7.13M 0.04% 353
2023
Q4
Sell
-900
Closed -$276K 2235
2023
Q3
$276K Buy
+900
New +$284K ﹤0.01% 1699

Other funds holding ACN

HRT Financial's ACN Position: Q1 2026 in Review

HRT Financial sold out of Accenture (ACN) in Q1 2026, closing a stake of 9,399 shares — an estimated $2.19M sold.

HRT Financial first reported a position in ACN in Q2 2018 and held it in 13 quarters. The position peaked at $42.7M in Q2 2024. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • HRT Financial reported no remaining Accenture position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 9,399 Accenture shares in Q1 2026, an estimated $2.19M.
  • HRT Financial first reported a position in Accenture in Q2 2018 and held it in 13 quarters.
  • HRT Financial's Accenture position peaked at $42.7M in Q2 2024.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.